Hepatocyte Response to Continuous Low Dose-rate Radiation in Radioimmunotherapy Assessed by Micronucleus Assay

References

• Berger M.U. Distribution of absorbed dose around point sources of electrons and beta particles in water and other media. Medical Internal Radiation Dose (MIRD) Pamphlet No. 7. Journal of Nuclear Medicine 1971, Suppl. 5: 7–23
   Google Scholar
• Braithwaite I., Ashby J. A non-invasive micronucleus assay in the rat liver. Mutation Research 1988; 203: 23–32
   PubMed Web of Science ®Google Scholar
• Brooks A.L. Chromosome damage in liver cells from low dose rate alpha, beta, and gamma irradiation: deviation of RBE. Science 1975; 190: 1090–1092
   PubMed Web of Science ®Google Scholar
• Brooks A.L. Low dose and low dose-rate effects on cytogenetics. Radiation Biology in Cancer Research, R.E. Meyne, H. Rodney Withers. Raven Press, New York 1980; 263–276, In
   Google Scholar
• Buchsbaum D.J., Ten Haken R.K., Heidorn D.B., Lawrence T.S., Glatfelter A.A., Terry V.H., Guilbault D.M., Steplewski Z., Lichter A.S. A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts. International Journal of Radiation Oncology, Biology and Physics 1990; 18: 1033–1041
   PubMed Web of Science ®Google Scholar
• Carrasquillo J.A., Krohn K.A., Beaumier P., McGuffin R.W., Brown J.P., Hellström K.E., Hellström I., Larson S.M. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments. Cancer Treatment Report 1984; 68: 317–328
   PubMedGoogle Scholar
• DeNardo S.J., DeNardo G.L., O'Grady L.F., Hu E., Systsma V.M., Mills S.L., Levy N.B., Macey D.J., Miller C.H., Epstein A.L. Treatment of B-cell maligancies with 131I-Lym-1 monoclonal antibodies. International Journal of Cancer 1988, Suppl. 3: 96–101
   PubMed Web of Science ®Google Scholar
• Epenetos A.A., Kosmas C. Monoclonal antibodies for imaging and therapy. British Journal of Cancer 1989; 51: 149–160
   Google Scholar
• Fenech M., Morley A.A. Measurement of micronuclei in lymphocytes. Mutation Research 1985; 147: 29–36
   PubMed Web of Science ®Google Scholar
• Fisher D.R., Hendry J.H., Scott D. Long-term repair in vivo of colony-forming ability and chromosomal injury in X-irradiated mouse hepatocytes. Radiation Research 1988; 113: 40–50
   PubMed Web of Science ®Google Scholar
• Fowler J.F. Radiobiological aspects of low dose rates in radioimmunotherapy. International Journal of Radiation Oncology, Biology and Physics 1990; 18: 1261–1269
   PubMed Web of Science ®Google Scholar
• Hnatowich D.J., Chinol M., Siebecker D.A., Gionet M., Griffin T., Doherty P.W., Hunter R., Kase K.R. Patient biodistribution of intraperitoneally-administered yttrium-90-labled antibody. Journal of Nuclear Medicine 1988; 29: 1428–1435
   PubMed Web of Science ®Google Scholar
• Langmuir V.K., Sutherland R.M. Radiobiology of radioimmunotherapy: current status. Antibody, Immunoconjugates, and Radiopharmaceuticals 1988; 1: 195–211
   Google Scholar
• Larson S.M. Radiolabeled monoclonal antitumor antibodies in diagnosis and therapy. Journal of Nuclear Medicine 1985; 26: 538–545
   PubMed Web of Science ®Google Scholar
• Matsuoka Y., Nakashima T., Endo K., Yoshida T., Kunimatsu M., Sakahara H., Koizumi M., Nakagawa T., Yamaguchi N., Torizuka K. Recognition of ovarian cancer antigen, CA125, by murine monoclonal antibody produced by immunization of lung cancer cells. Cancer Research 1987; 47: 6335–6340
   PubMed Web of Science ®Google Scholar
• Ono K., Nagata Y., Akuta K., Abe M., Ando K., Koike S. Frequency of micronuclei in hepatocytes following X and fast-neutron irradiations—an analysis by a linear-quadratic model. Radiation Research 1990; 123: 345–347
   PubMed Web of Science ®Google Scholar
• Order S.E. Presidential address: systemic radiotherapy—the new frontier. International Journal of Radiation Oncology, Biology and Physics 1990; 18: 981–992
   PubMed Web of Science ®Google Scholar
• Saga T., Ishikawa I., Endo K., Sakahara H., Koizumi M., Watanabe Y., Nakai T., Hosono M., Ishikawa H., Sawada M., Konishi J. An antibodytumor model for the targeting of CA125-producing gynecologic malignancies. Japanese Journal of Cancer Research (Gann) 1990; 81: 1141–1148
   PubMedGoogle Scholar
• Sakahara H., Endo K., Nakashima T., Koizumi M., Kunimatsu M., Kawamura Y., Ohta H., Nakamura T., Tanaka H., Kotoura Y., Yamamuro T., Hosoi S., Toyama S., Torizuka K. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody with radioiodine and indium-111. Journal of Nuclear Medicine 1987; 28: 342–348
   PubMed Web of Science ®Google Scholar
• Sakahara H., Endo K., Koizumi M., Nakashima T., Kunimatsu M., Watanabe Y., Kawamura Y., Tanaka H., Kotoura Y., Yamamuro T., Hosoi S., Toyama S., Torizuka K. Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies. Journal of Nuclear Medicine 1988; 29: 235–240
   PubMed Web of Science ®Google Scholar
• Tates A.D., Broerse J.J., Neuteboom I., de Vogel N. Differential persistence of chromosomal damage induced in resting rat-liver cells by X-rays and 4·2-MeV neutrons. Mutation Research 1982; 92: 275–290
   PubMed Web of Science ®Google Scholar
• Wheldon T.E., O'Donoghue J.A. The radiobiology of targeted radiotherapy. International Journal of Radiation Biology 1990; 58: 1–21
   PubMed Web of Science ®Google Scholar
• Withers H.R., Peters L.J. Biological aspects of radiation therapy. Textbook of Radiotherapy3rd edn., G.H. Fretcher. Lea & Febiger, Philadelpha 1980; 103–180, In
   Google Scholar